Cipla Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 31.69 |
ISIN Demat : INE059A01026 |
Div & Yield% : 0.83 |
EPS(TTM) : 49.18 |
Book Value(₹) : 346.40 |
Market Cap(₹Cr) : 125,847.20 |
Face Value(₹) : 2.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 3,752.25 | 3,444.92 | 3,798.31 | 3,736.46 | 3,857.73 | 3,157.82 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 3,752.25 | 3,444.92 | 3,798.31 | 3,736.46 | 3,857.73 | 3,157.82 |
Other Operating Income | 748.80 | 591.74 | 583.02 | 497.98 | 460.46 | 408.06 |
Other Income | 213.52 | 594.98 | 265.36 | 319.24 | 157.98 | 184.89 |
Total Income | 4,714.57 | 4,631.64 | 4,646.69 | 4,553.68 | 4,476.17 | 3,750.77 |
Total Expenditure | 3,141.19 | 3,208.77 | 3,025.47 | 3,009.06 | 3,113.50 | 3,040.29 |
PBIDT | 1,573.38 | 1,422.87 | 1,621.22 | 1,544.62 | 1,362.67 | 710.48 |
Interest | 5.07 | 5.45 | 9.06 | 6.61 | 0.31 | 9.27 |
PBDT | 1,568.31 | 1,417.42 | 1,612.16 | 1,538.01 | 1,362.36 | 701.21 |
Depreciation | 137.86 | 136.81 | 135.02 | 179.81 | 135.95 | 161.58 |
Tax | 357.92 | 240.18 | 348.69 | 329.81 | 340.34 | 222.72 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 16.59 | 2.03 | 14.31 | -1.30 | -8.95 | -38.58 |
Reported Profit After Tax | 1,055.94 | 1,038.40 | 1,114.14 | 1,029.69 | 895.02 | 355.49 |
Extra-ordinary Items | 0.00 | 56.37 | 96.38 | 114.15 | 0.00 | -33.45 |
Adjusted Profit After Extra-ordinary item | 1,055.94 | 982.03 | 1,017.76 | 915.54 | 895.02 | 388.94 |
EPS (Unit Curr.) | 13.08 | 12.86 | 14.99 | 14.17 | 11.09 | 4.40 |
EPS (Adj) (Unit Curr.) | 13.08 | 12.86 | 14.99 | 14.17 | 11.09 | 4.40 |
Calculated EPS (Unit Curr.) | 13.08 | 12.86 | 13.80 | 12.75 | 11.09 | 4.40 |
Calculated EPS (Adj) (Unit Curr.) | 13.08 | 12.86 | 13.80 | 12.75 | 11.09 | 4.40 |
Calculated EPS (Ann.) (Unit Curr.) | 52.31 | 51.45 | 55.20 | 51.02 | 44.35 | 17.62 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 52.31 | 51.45 | 55.20 | 51.02 | 44.35 | 17.62 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 650.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 161.50 | 161.47 | 161.47 | 161.47 | 161.45 | 161.43 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 41.93 | 41.30 | 42.68 | 41.34 | 35.32 | 22.50 |
PBDTM(%) | 41.80 | 41.15 | 42.44 | 41.16 | 35.32 | 22.21 |
PATM(%) | 28.14 | 30.14 | 29.33 | 27.56 | 23.20 | 11.26 |